US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CALCIMEDICA

0.8178

-0.1122-12.06%

Post-market: 0.8044-0.0134-1.64%19:53 EDT

Volume:575.30K

Turnover:496.74K

Market Cap:12.92M

PE:-0.64

High:0.9247

Open:0.9100

Low:0.8001

Close:0.9300

52wk High:7.20

52wk Low:0.4606

Shares:15.80M

Float Shares:990.60K

Volume Ratio:1.77

T/O Rate:58.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2684

EPS(LYR):-1.9700

ROE:-399.51%

ROA:-81.85%

PB:-11.70

PE(LYR):-0.42

Loading ...

Overview Company News Filings

CalciMedica posts FY 2025 net loss of USD 29.6 million, up 2.2x

CalciMedica Reports 2025 Financial Results and Provides Clinical Updates

THOMSON REUTERS

This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Benzinga_recent_news

HC Wainwright Downgrades CalciMedica to Neutral From Buy

MT Newswires Live

CalciMedica Cut to Neutral From Buy by HC Wainwright & Co.

CalciMedica downgraded to Neutral from Buy at H.C. Wainwright

CalciMedica Inc - Discontinues Phase 2 Kourage Trial - SEC Filing

THOMSON REUTERS

CalciMedica: Updates Financial Guidance After Trial Discontinuation, NOW Expects Funds to Last Into Q4 2026 - SEC Filing

THOMSON REUTERS

CalciMedica Extends Cash Runway Into Fourth Quarter of 2026

Calcimedica Inc trading resumes

CalciMedica Shares Hit 52-Week Low After Ending Auxora Trial

BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International

BUZZ-CalciMedica tumbles as safety concerns halt trial of kidney injury drug

CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial

BRIEF-CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee Recommendation

CalciMedica Inc: Safety Concern Warrants Reevaluation of Study Design, Including Enrollment Criteria

THOMSON REUTERS

CalciMedica Inc: There Were No Deaths in Trial That Were Assessed by Investigators or CalciMedica as Being Related to Study Drug

THOMSON REUTERS

CalciMedica Inc: Potential Future Trial With Auxora in Aki to Be Evaluated After Data Analysis

THOMSON REUTERS

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CALC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CALC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":0.8178,"timestamp":1783972800000,"preClose":0.93,"halted":0,"volume":575302,"hourTrading":{"tag":"盘后","latestPrice":0.804401,"preClose":0.8178,"latestTime":"19:53 EDT","volume":18018,"amount":15110.9792,"timestamp":1783986803516,"change":-0.013399,"changeRate":-0.016384,"amplitude":0.097212},"delay":0,"changeRate":-0.12064516129032266,"floatShares":990597,"shares":15798000,"eps":-1.268395,"marketStatus":"Not Yet Opened","change":-0.1122,"latestTime":"07-13 16:00:00 EDT","open":0.91,"high":0.924737,"low":0.8001,"amount":496742.32575240004,"amplitude":0.134018,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.268395,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784016000000},"marketStatusCode":0,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":0.93,"preHourTrading":{"tag":"盘前","latestPrice":0.9101,"preClose":0.93,"latestTime":"09:26 EDT","volume":3271,"amount":2950.21685707,"timestamp":1783949177766,"change":-0.0199,"changeRate":-0.021398,"amplitude":0.043011},"postHourTrading":{"tag":"盘后","latestPrice":0.804401,"preClose":0.8178,"latestTime":"19:53 EDT","volume":18018,"amount":15110.9792,"timestamp":1783986803516,"change":-0.013399,"changeRate":-0.016384,"amplitude":0.097212},"volumeRatio":1.769342,"impliedVol":1.8027,"impliedVolPercentile":0.8952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","floatShares":990597,"roa":"-81.85%","roe":"-399.51%","lyrEps":-1.969999,"volumeRatio":1.769342,"shares":15798000,"dividePrice":0,"high":0.924737,"amplitude":0.134018,"preClose":0.93,"low":0.8001,"week52Low":0.4606,"pbRate":"-11.70","week52High":7.2,"institutionHeld":0,"latestPrice":0.8178,"eps":-1.268395,"divideRate":0,"volume":575302,"delay":0,"ttmEps":-1.268395,"open":0.91,"prevYearClose":6.59,"prevWeekClose":0.93,"prevMonthClose":1.03,"prevQuarterClose":1.03,"fiveDayClose":0.988,"twentyDayClose":0.8915,"sixtyDayClose":0.6351},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CALC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"CALC","fiscalQuarterEnding":"2026/03","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2026-03-03","symbol":"CALC","fiscalQuarterEnding":"2025/12","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772514000000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-11-12","symbol":"CALC","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2025-08-12","symbol":"CALC","fiscalQuarterEnding":"2025/06","expectedEps":-0.4,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-05-14","symbol":"CALC","fiscalQuarterEnding":"2025/03","expectedEps":-0.43,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CALC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CALC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1769918400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CALC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CALC","date":"2026-07-10","current":-0.644752,"percent":0.818033,"low":-4.525842,"twenty":-3.334606,"median":-2.033995,"eighty":-0.943945,"high":-0.276938,"avg":-2.085707,"sd":1.125695,"marketCap":15006549},"quantilePoints":[{"date":"2024-01-05","current":-0.71129,"twenty":-0.71129,"median":-0.71129,"eighty":-0.71129,"marketCap":20480891},{"date":"2024-01-12","current":-0.644854,"twenty":-0.706809,"median":-0.663373,"eighty":-0.661399,"marketCap":18567932},{"date":"2024-01-19","current":-0.842346,"twenty":-0.707705,"median":-0.673245,"eighty":-0.662978,"marketCap":24254510},{"date":"2024-01-26","current":-1.017241,"twenty":-1.012132,"median":-0.706809,"eighty":-0.663373,"marketCap":29290430},{"date":"2024-02-02","current":-2.31259,"twenty":-1.35801,"median":-0.893146,"eighty":-0.671271,"marketCap":66588713},{"date":"2024-02-09","current":-1.906022,"twenty":-2.088582,"median":-1.017241,"eighty":-0.673245,"marketCap":54881987},{"date":"2024-02-16","current":-1.682223,"twenty":-2.119115,"median":-1.116267,"eighty":-0.690619,"marketCap":48437918},{"date":"2024-02-23","current":-1.643058,"twenty":-2.095833,"median":-1.634666,"eighty":-0.702071,"marketCap":47310206},{"date":"2024-03-01","current":-1.633733,"twenty":-2.020905,"median":-1.643058,"eighty":-0.709498,"marketCap":47041703},{"date":"2024-03-08","current":-1.652383,"twenty":-1.962717,"median":-1.659843,"eighty":-0.789924,"marketCap":47578709},{"date":"2024-03-15","current":-1.626273,"twenty":-1.923926,"median":-1.652383,"eighty":-0.903305,"marketCap":46826901},{"date":"2024-03-22","current":-1.428584,"twenty":-1.903784,"median":-1.64026,"eighty":-0.984091,"marketCap":41134640},{"date":"2024-03-28","current":-1.309808,"twenty":-1.864992,"median":-1.631159,"eighty":-1.013409,"marketCap":45001081},{"date":"2024-04-05","current":-1.359825,"twenty":-1.759493,"median":-1.626273,"eighty":-1.046819,"marketCap":46719500},{"date":"2024-04-12","current":-1.378581,"twenty":-1.683991,"median":-1.551673,"eighty":-1.099979,"marketCap":47363907},{"date":"2024-04-19","current":-1.25354,"twenty":-1.680731,"median":-1.469614,"eighty":-1.115647,"marketCap":43067861},{"date":"2024-04-26","current":-1.653672,"twenty":-1.680731,"median":-1.452232,"eighty":-1.163031,"marketCap":56815208},{"date":"2024-05-03","current":-1.87562,"twenty":-1.717206,"median":-1.540483,"eighty":-1.238535,"marketCap":64440690},{"date":"2024-05-10","current":-1.766209,"twenty":-1.764959,"median":-1.622543,"eighty":-1.25479,"marketCap":60681649},{"date":"2024-05-17","current":-3.903797,"twenty":-1.803163,"median":-1.628585,"eighty":-1.259167,"marketCap":58318824},{"date":"2024-05-24","current":-3.709686,"twenty":-1.90453,"median":-1.64026,"eighty":-1.263536,"marketCap":55418993},{"date":"2024-05-31","current":-4.076341,"twenty":-2.061189,"median":-1.652383,"eighty":-1.269686,"marketCap":60896452},{"date":"2024-06-07","current":-3.763144,"twenty":-2.28275,"median":-1.667303,"eighty":-1.292545,"marketCap":56217609},{"date":"2024-06-14","current":-3.626433,"twenty":-2.775108,"median":-1.674763,"eighty":-1.30043,"marketCap":54175287},{"date":"2024-06-21","current":-3.741558,"twenty":-3.626433,"median":-1.678493,"eighty":-1.306682,"marketCap":55895138},{"date":"2024-06-28","current":-2.266521,"twenty":-3.626433,"median":-1.678493,"eighty":-1.308558,"marketCap":33859554},{"date":"2024-07-05","current":-3.0652,"twenty":-3.626433,"median":-1.678493,"eighty":-1.309808,"marketCap":45791016},{"date":"2024-07-12","current":-3.396184,"twenty":-3.511308,"median":-1.683696,"eighty":-1.342725,"marketCap":50735586},{"date":"2024-07-15","current":-3.518504,"twenty":-3.517065,"median":-1.685169,"eighty":-1.342739,"marketCap":52562927},{"date":"2024-08-02","current":-3.223823,"twenty":-3.515626,"median":-1.694429,"eighty":-1.342753,"marketCap":48160698},{"date":"2024-08-09","current":-3.346156,"twenty":-3.502674,"median":-1.717881,"eighty":-1.345855,"marketCap":49988225},{"date":"2024-08-16","current":-3.501123,"twenty":-3.583261,"median":-1.750157,"eighty":-1.351697,"marketCap":44075639},{"date":"2024-08-23","current":-3.569438,"twenty":-3.582315,"median":-1.766209,"eighty":-1.354811,"marketCap":44935652},{"date":"2024-08-30","current":-3.67191,"twenty":-3.613882,"median":-1.801693,"eighty":-1.356667,"marketCap":46225670},{"date":"2024-09-06","current":-4.397752,"twenty":-3.637946,"median":-1.869368,"eighty":-1.357299,"marketCap":55363303},{"date":"2024-09-13","current":-3.552359,"twenty":-3.65203,"median":-1.906022,"eighty":-1.362326,"marketCap":44720648},{"date":"2024-09-20","current":-3.53528,"twenty":-3.640824,"median":-2.030976,"eighty":-1.373579,"marketCap":44505645},{"date":"2024-09-27","current":-3.859775,"twenty":-3.700214,"median":-2.125233,"eighty":-1.378581,"marketCap":48590705},{"date":"2024-10-04","current":-3.740224,"twenty":-3.708962,"median":-2.289556,"eighty":-1.380457,"marketCap":47085683},{"date":"2024-10-11","current":-3.371069,"twenty":-3.708962,"median":-2.722888,"eighty":-1.392648,"marketCap":42438390},{"date":"2024-10-18","current":-3.381146,"twenty":-3.700214,"median":-2.935837,"eighty":-1.41484,"marketCap":42565242},{"date":"2024-10-25","current":-3.53528,"twenty":-3.675822,"median":-3.058004,"eighty":-1.429837,"marketCap":44505645},{"date":"2024-10-31","current":-4.098876,"twenty":-3.6768,"median":-3.0652,"eighty":-1.43485,"marketCap":51600748},{"date":"2024-11-08","current":-3.744979,"twenty":-3.72195,"median":-3.072551,"eighty":-1.469614,"marketCap":47145546},{"date":"2024-11-15","current":-3.340773,"twenty":-3.734279,"median":-3.223823,"eighty":-1.536753,"marketCap":45394425},{"date":"2024-11-22","current":-3.420079,"twenty":-3.72195,"median":-3.270562,"eighty":-1.540483,"marketCap":46472038},{"date":"2024-11-29","current":-3.423065,"twenty":-3.714694,"median":-3.298285,"eighty":-1.558387,"marketCap":46512613},{"date":"2024-12-06","current":-2.966657,"twenty":-3.710325,"median":-3.295449,"eighty":-1.607623,"marketCap":40310931},{"date":"2024-12-13","current":-2.768218,"twenty":-3.706791,"median":-3.249448,"eighty":-1.624781,"marketCap":37614548},{"date":"2024-12-20","current":-2.748374,"twenty":-3.682653,"median":-3.194715,"eighty":-1.626273,"marketCap":37344910},{"date":"2024-12-27","current":-2.986501,"twenty":-3.673866,"median":-3.079903,"eighty":-1.62766,"marketCap":40580570},{"date":"2025-01-03","current":-3.264315,"twenty":-3.665078,"median":-3.095642,"eighty":-1.630644,"marketCap":44355506},{"date":"2025-01-10","current":-2.976579,"twenty":-3.653123,"median":-3.165095,"eighty":-1.634479,"marketCap":40445751},{"date":"2025-01-17","current":-3.145251,"twenty":-3.645198,"median":-3.087772,"eighty":-1.638582,"marketCap":42737676},{"date":"2025-01-24","current":-2.867437,"twenty":-3.640824,"median":-3.065538,"eighty":-1.643058,"marketCap":38962740},{"date":"2025-01-31","current":-2.52017,"twenty":-3.640824,"median":-3.058004,"eighty":-1.652383,"marketCap":34244069},{"date":"2025-02-07","current":-2.688843,"twenty":-3.640824,"median":-3.04842,"eighty":-1.652383,"marketCap":36535995},{"date":"2025-02-14","current":-2.649155,"twenty":-3.63798,"median":-3.022334,"eighty":-1.653672,"marketCap":35996718},{"date":"2025-02-21","current":-2.420951,"twenty":-3.628742,"median":-2.996423,"eighty":-1.664577,"marketCap":32895877},{"date":"2025-02-28","current":-2.2622,"twenty":-3.626433,"median":-2.986501,"eighty":-1.670287,"marketCap":30738770},{"date":"2025-03-07","current":-2.182824,"twenty":-3.621826,"median":-2.966657,"eighty":-1.674017,"marketCap":29660217},{"date":"2025-03-14","current":-1.885166,"twenty":-3.613842,"median":-2.897203,"eighty":-1.674763,"marketCap":25615642},{"date":"2025-03-21","current":-2.083605,"twenty":-3.598472,"median":-2.84934,"eighty":-1.677747,"marketCap":28312025},{"date":"2025-03-28","current":-2.053839,"twenty":-3.588224,"median":-2.832711,"eighty":-1.678493,"marketCap":27907568},{"date":"2025-04-04","current":-1.800869,"twenty":-3.578114,"median":-2.788062,"eighty":-1.678493,"marketCap":24671908},{"date":"2025-04-11","current":-1.456441,"twenty":-3.570753,"median":-2.763257,"eighty":-1.678493,"marketCap":19953237},{"date":"2025-04-17","current":-1.515486,"twenty":-3.564314,"median":-2.743413,"eighty":-1.673271,"marketCap":20762152},{"date":"2025-04-25","current":-1.500724,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"marketCap":20559923},{"date":"2025-05-02","current":-1.525326,"twenty":-3.542112,"median":-2.713647,"eighty":-1.631674,"marketCap":20896971},{"date":"2025-05-09","current":-2.027208,"twenty":-3.53528,"median":-2.688843,"eighty":-1.635971,"marketCap":27772749},{"date":"2025-05-16","current":-1.385911,"twenty":-3.53528,"median":-2.683882,"eighty":-1.635971,"marketCap":26154918},{"date":"2025-05-23","current":-1.266008,"twenty":-3.530157,"median":-2.649155,"eighty":-1.623289,"marketCap":23892102},{"date":"2025-05-30","current":-1.292809,"twenty":-3.523446,"median":-2.629311,"eighty":-1.56753,"marketCap":24397888},{"date":"2025-06-06","current":-1.243723,"twenty":-3.518383,"median":-2.599038,"eighty":-1.538245,"marketCap":23471546},{"date":"2025-06-13","current":-1.295622,"twenty":-3.515866,"median":-2.540014,"eighty":-1.518241,"marketCap":24450982},{"date":"2025-06-20","current":-1.251201,"twenty":-3.512152,"median":-2.500326,"eighty":-1.501708,"marketCap":23612663},{"date":"2025-06-27","current":-1.058708,"twenty":-3.509535,"median":-2.41599,"eighty":-1.481761,"marketCap":19979945},{"date":"2025-07-03","current":-1.191972,"twenty":-3.502441,"median":-2.36638,"eighty":-1.456441,"marketCap":22494903},{"date":"2025-07-11","current":-1.199376,"twenty":-3.501123,"median":-2.291966,"eighty":-1.387959,"marketCap":22634623},{"date":"2025-07-18","current":-1.865696,"twenty":-3.489723,"median":-2.257239,"eighty":-1.411404,"marketCap":35209414},{"date":"2025-07-25","current":-2.731912,"twenty":-3.484044,"median":-2.266521,"eighty":-1.428584,"marketCap":51556643},{"date":"2025-08-01","current":-2.546823,"twenty":-3.475505,"median":-2.322122,"eighty":-1.43485,"marketCap":48063645},{"date":"2025-08-08","current":-2.154435,"twenty":-3.454157,"median":-2.266521,"eighty":-1.456441,"marketCap":40658490},{"date":"2025-08-15","current":-1.747024,"twenty":-3.441348,"median":-2.255181,"eighty":-1.469614,"marketCap":36467381},{"date":"2025-08-22","current":-1.867509,"twenty":-3.437078,"median":-2.222512,"eighty":-1.476122,"marketCap":38982373},{"date":"2025-08-29","current":-1.827347,"twenty":-3.425123,"median":-2.219309,"eighty":-1.480711,"marketCap":38144043},{"date":"2025-09-05","current":-2.121865,"twenty":-3.423477,"median":-2.192746,"eighty":-1.480711,"marketCap":44291801},{"date":"2025-09-12","current":-2.295898,"twenty":-3.423065,"median":-2.202668,"eighty":-1.484913,"marketCap":47924567},{"date":"2025-09-19","current":-2.148639,"twenty":-3.420676,"median":-2.179735,"eighty":-1.493836,"marketCap":44850688},{"date":"2025-09-26","current":-2.014767,"twenty":-3.420079,"median":-2.162026,"eighty":-1.495804,"marketCap":42056252},{"date":"2025-10-03","current":-2.041542,"twenty":-3.420079,"median":-2.153747,"eighty":-1.49974,"marketCap":42615139},{"date":"2025-10-10","current":-2.26243,"twenty":-3.414618,"median":-2.154435,"eighty":-1.504661,"marketCap":47225958},{"date":"2025-10-17","current":-2.175413,"twenty":-3.408403,"median":-2.154883,"eighty":-1.509581,"marketCap":45409575},{"date":"2025-10-24","current":-2.054929,"twenty":-3.404016,"median":-2.148639,"eighty":-1.514502,"marketCap":42894583},{"date":"2025-10-31","current":-2.00138,"twenty":-3.397592,"median":-2.141945,"eighty":-1.51728,"marketCap":41776809},{"date":"2025-11-07","current":-2.048235,"twenty":-3.391326,"median":-2.133215,"eighty":-1.521445,"marketCap":42754861},{"date":"2025-11-14","current":-2.162026,"twenty":-3.383731,"median":-2.134233,"eighty":-1.524736,"marketCap":45130131},{"date":"2025-11-21","current":-1.974579,"twenty":-3.381686,"median":-2.132574,"eighty":-1.525326,"marketCap":45533801},{"date":"2025-11-28","current":-2.668182,"twenty":-3.381573,"median":-2.133215,"eighty":-1.532182,"marketCap":61528270},{"date":"2025-12-05","current":-2.855642,"twenty":-3.381317,"median":-2.141945,"eighty":-1.538991,"marketCap":65851099},{"date":"2025-12-12","current":-2.868139,"twenty":-3.3751,"median":-2.148639,"eighty":-1.543198,"marketCap":66139288},{"date":"2025-12-19","current":-3.061848,"twenty":-3.367124,"median":-2.153747,"eighty":-1.550913,"marketCap":70606211},{"date":"2025-12-26","current":-3.880424,"twenty":-3.381573,"median":-2.158679,"eighty":-1.558055,"marketCap":89482566},{"date":"2026-01-02","current":-4.117873,"twenty":-3.39497,"median":-2.162708,"eighty":-1.565196,"marketCap":94958150},{"date":"2026-01-09","current":-3.330541,"twenty":-3.412041,"median":-2.175413,"eighty":-1.57623,"marketCap":76802267},{"date":"2026-01-16","current":-3.299297,"twenty":-3.419668,"median":-2.176029,"eighty":-1.587039,"marketCap":76081795},{"date":"2026-01-23","current":-3.336789,"twenty":-3.420079,"median":-2.182466,"eighty":-1.603069,"marketCap":76946361},{"date":"2026-01-30","current":-0.637364,"twenty":-3.420079,"median":-2.182824,"eighty":-1.583031,"marketCap":14697619},{"date":"2026-02-06","current":-0.381731,"twenty":-3.418022,"median":-2.176029,"eighty":-1.545008,"marketCap":8802721},{"date":"2026-02-13","current":-0.437407,"twenty":-3.413253,"median":-2.175413,"eighty":-1.525326,"marketCap":10086601},{"date":"2026-02-20","current":-0.325681,"twenty":-3.408403,"median":-2.163391,"eighty":-1.514502,"marketCap":7510195},{"date":"2026-02-27","current":-0.344926,"twenty":-3.404016,"median":-2.158679,"eighty":-1.495804,"marketCap":7954005},{"date":"2026-03-06","current":-0.352031,"twenty":-3.397592,"median":-2.153059,"eighty":-1.479793,"marketCap":10406728},{"date":"2026-03-13","current":-0.386648,"twenty":-3.391326,"median":-2.148639,"eighty":-1.433597,"marketCap":11430083},{"date":"2026-03-20","current":-0.392772,"twenty":-3.383731,"median":-2.141945,"eighty":-1.384445,"marketCap":11611138},{"date":"2026-03-27","current":-0.310224,"twenty":-3.381686,"median":-2.132894,"eighty":-1.376115,"marketCap":9170831},{"date":"2026-04-02","current":-0.313259,"twenty":-3.381573,"median":-2.123549,"eighty":-1.358562,"marketCap":9260571},{"date":"2026-04-10","current":-0.346705,"twenty":-3.381317,"median":-2.118518,"eighty":-1.347386,"marketCap":10249289},{"date":"2026-04-17","current":-0.324869,"twenty":-3.377027,"median":-2.107577,"eighty":-1.329678,"marketCap":9603788},{"date":"2026-04-24","current":-0.308892,"twenty":-3.372354,"median":-2.09509,"eighty":-1.301988,"marketCap":9131471},{"date":"2026-05-01","current":-0.314218,"twenty":-3.367124,"median":-2.089288,"eighty":-1.294497,"marketCap":9288910},{"date":"2026-05-08","current":-0.338397,"twenty":-3.363918,"median":-2.081703,"eighty":-1.271931,"marketCap":10003684},{"date":"2026-05-15","current":-0.547783,"twenty":-3.358987,"median":-2.071662,"eighty":-1.263846,"marketCap":10705862},{"date":"2026-05-22","current":-0.507504,"twenty":-3.352794,"median":-2.063761,"eighty":-1.252604,"marketCap":9918667},{"date":"2026-05-29","current":-0.700839,"twenty":-3.348874,"median":-2.061622,"eighty":-1.234608,"marketCap":13697206},{"date":"2026-06-05","current":-0.685212,"twenty":-3.344003,"median":-2.05537,"eighty":-1.209741,"marketCap":13391774},{"date":"2026-06-12","current":-0.718159,"twenty":-3.340014,"median":-2.053839,"eighty":-1.191972,"marketCap":14035701},{"date":"2026-06-18","current":-0.676673,"twenty":-3.338876,"median":-2.048235,"eighty":-1.178646,"marketCap":13224889},{"date":"2026-06-26","current":-0.506177,"twenty":-3.338459,"median":-2.042461,"eighty":-1.123522,"marketCap":9892727},{"date":"2026-07-02","current":-0.840665,"twenty":-3.336789,"median":-2.038195,"eighty":-1.058708,"marketCap":16429952},{"date":"2026-07-10","current":-0.767834,"twenty":-3.334606,"median":-2.033995,"eighty":-0.943945,"marketCap":15006549}],"updateTime":1783992407354},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CALC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616342894","title":"CalciMedica posts FY 2025 net loss of USD 29.6 million, up 2.2x","url":"https://stock-news.laohu8.com/highlight/detail?id=2616342894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616342894?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:01","pubTimestamp":1772539276,"startTime":"0","endTime":"0","summary":"CalciMedica reported a FY 2025 net loss of USD 29.6 million and a loss per share of USD 1.97. R&D expenses were USD 15.2 million and G&A expenses were USD 7.9 million. Cash, cash equivalents and short-term investments totaled USD 13.0 million at December 31, 2025, which CalciMedica said is expected to fund its current operating plan into Q4 2026. On the pipeline, CalciMedica said internal and external reviews of unblinded Phase 2 KOURAGE data in acute kidney injury with acute hypoxemic respiratory failure found no evidence of drug-related toxicity with Auxora, after the trial was discontinued in January 2026 following an IDMC recommendation tied to a mortality imbalance. The company plans to discuss the KOURAGE data and potential future AKI development with the FDA in Q2 2026. In acute pancreatitis, CalciMedica said it expects to finalize the design of its pivotal Auxora program in H1 2026 following FDA engagement, and highlighted publication of Phase 2b CARPO results in eClinicalMedic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL4dYZbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616447233","title":"CalciMedica Reports 2025 Financial Results and Provides Clinical Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2616447233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616447233?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:00","pubTimestamp":1772539204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUABGRRWN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607349270","title":"This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2607349270","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607349270?lang=en_us&edition=fundamental","pubTime":"2026-01-30 00:28","pubTimestamp":1769704080,"startTime":"0","endTime":"0","summary":"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.\nConsidering buying CALC stock? Here’s what analysts think: \nPhoto via Shutterstock","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/29/Analyst-Woman-Working-With-Information-D_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/29/Analyst-Woman-Working-With-Information-D_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/26/01/50237685/this-calcimedica-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-thursday","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/26/01/50237685/this-calcimedica-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4112","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607847600","title":"HC Wainwright Downgrades CalciMedica to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2607847600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607847600?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:26","pubTimestamp":1769689587,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) has an average rating of overweight and mean price target of $16.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607089704","title":"CalciMedica Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2607089704","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607089704?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:52","pubTimestamp":1769687520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 29, 2026 06:52 ET (11:52 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607865370","title":"CalciMedica downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2607865370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607865370?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:11","pubTimestamp":1769685078,"startTime":"0","endTime":"0","summary":"H.C. Wainwright downgraded CalciMedica (CALC) to Neutral from Buy without a price target The immediate discontinuation for the Phase 2 KOURAGE clin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607726109","title":"CalciMedica Inc - Discontinues Phase 2 Kourage Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607726109?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:30","pubTimestamp":1769639432,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607272643","title":"CalciMedica: Updates Financial Guidance After Trial Discontinuation, NOW Expects Funds to Last Into Q4 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607272643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607272643?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:30","pubTimestamp":1769639432,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1EW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607726157","title":"CalciMedica Extends Cash Runway Into Fourth Quarter of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607726157?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:29","pubTimestamp":1769639376,"startTime":"0","endTime":"0","summary":"CalciMedica Inc. has updated its financial guidance following the discontinuation of its Phase 2 KOURAGE clinical trial. The company now anticipates that its existing cash, cash equivalents, and short-term investments will be sufficient to fund its current operating plan into the fourth quarter of 2026. This marks an improvement from its previous expectation, which projected funding only into the second half of 2026, reflecting a reduction in planned operating expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL2Nxtt1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607774346","title":"Calcimedica Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2607774346","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607774346?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:40","pubTimestamp":1769614822,"startTime":"0","endTime":"0","summary":"10:35 EST Calcimedica (CALC) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606748845","title":"CalciMedica Shares Hit 52-Week Low After Ending Auxora Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2606748845","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606748845?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:09","pubTimestamp":1769612940,"startTime":"0","endTime":"0","summary":"CalciMedica shares were 82% lower, at 91 cents, after the company said it was discontinuing its Phase 2 clinical trial evaluating Auxora in patients with Stage 2 or Stage 3 acute kidney injury with associated acute hypoxemic respiratory failure.The stock hit its 52-week low of 82 cents earlier in the session, and is down 66% in the past 12 months.The clinical-stage biopharmaceutical company said the decision follows a recommendation from the trial's independent data monitoring committee.During a prescheduled interim data review, the committee identified a safety concern that, in its view, warrants reevaluation of the study design, particularly with respect to patient enrollment criteria.The company said that there were no deaths in the trial that were assessed by investigators or CalciMedica as being related to study drug, with either Auxora or a placebo. No serious adverse events met the criteria for expedited reporting to the Food and Drug Administration.Based on the committee's reco","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606122327","title":"BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International","url":"https://stock-news.laohu8.com/highlight/detail?id=2606122327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606122327?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:12","pubTimestamp":1769609521,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker InternationalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nL6N3YT0MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","GEV","OTIS","BK4535","RGNX","GILD","LU0795875169.SGD","CALC","ADM","SBUX","IE0009355771.USD","LU0314106906.USD","MRK","DHR","LU2430703095.HKD","T","PPG","IE00B894F039.SGD","CDE","GKOS","QRVO","KYIV","VFC","WIX","HL","LU0211327993.USD","LU2430703178.SGD","NEM","TXT","LU0823431563.USD","EXTR","BROS","FFIV","STEL","EAT","LU1074936037.SGD","ELV","VEON","LU1551013425.SGD","AI","SARO","NXT","AU","LU0320765489.SGD","LU1489326972.SGD","LU0985481810.HKD","LU1291159041.SGD","TXN","ABBV"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2606971120","title":"BUZZ-CalciMedica tumbles as safety concerns halt trial of kidney injury drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2606971120","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606971120?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:29","pubTimestamp":1769606953,"startTime":"0","endTime":"0","summary":"BUZZ-CalciMedica tumbles as safety concerns halt trial of kidney injury drug** Shares of drug developer CalciMedica CALC.O fall 84% to 84 cents premarket** Co says an independent committee flagged safety concerns in the midstage trial of Auxora for severe kidney injury, which could impact the organ's functioning** Committee asked the co to review how patients were being enrolled** No deaths were linked to the drug and no serious side effects required urgent FDA reporting, per co** Co says it will review the data to decide if Auxora can be tested again; all enrolled patients will complete followup** Auxora had previously been tested in pancreatitis and COVID19 pneumonia without major safety issues, per co** Shares up ~86% in 2025","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nL4N3YT1IY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606378716","title":"CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2606378716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606378716?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:12","pubTimestamp":1769602327,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) announced the discontinuation of its Phase 2 KOURAGE clinical trial evaluating Auxora in patients with Stage 2 or Stage 3 acute ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-discontinuation-of-phase-2-kourage-clinical-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-discontinuation-of-phase-2-kourage-clinical-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606151537","title":"BRIEF-CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2606151537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606151537?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:05","pubTimestamp":1769601915,"startTime":"0","endTime":"0","summary":"BRIEF-CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee RecommendationJan 28 (Reuters) - CalciMedica Inc CALC.O:CALCIMEDICA ANNOUNCE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606771303","title":"CalciMedica Inc: Safety Concern Warrants Reevaluation of Study Design, Including Enrollment Criteria","url":"https://stock-news.laohu8.com/highlight/detail?id=2606771303","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606771303?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:00","pubTimestamp":1769601602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606510715","title":"CalciMedica Inc: There Were No Deaths in Trial That Were Assessed by Investigators or CalciMedica as Being Related to Study Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2606510715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606510715?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:00","pubTimestamp":1769601602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606171584","title":"CalciMedica Inc: Potential Future Trial With Auxora in Aki to Be Evaluated After Data Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2606171584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606171584?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:00","pubTimestamp":1769601602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606713125","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 06:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2606713125","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606713125?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:55","pubTimestamp":1769601300,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 06:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nAQN2LJLVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}